ARQT

Arcutis Biotherapeutics, Inc.

6 catalysts on file

ARQT

Arcutis Biotherapeutics, Inc.

Approval Confirmed

ZORYVE (roflumilast) Cream 0.3%

Plaque Psoriasis in children (age 2+)

98d ago Jun 29, 2026

Press release verified 3mo ago

Countdown card →

ARQT

Arcutis Biotherapeutics, Inc.

PDUFA Confirmed

ZORYVE

plaque psoriasis

98d ago Jun 29, 2026

SEC 8-K verified 3mo ago

Countdown card →

ARQT

Arcutis Biotherapeutics, Inc.

Phase 2 AI-extracted

ZORYVE

atopic dermatitis

97d ago ~ Jun 30, 2026

SEC 8-K verified 3mo ago

Countdown card →

ARQT

Arcutis Biotherapeutics, Inc.

Approval AI-extracted

ZORYVE

plaque psoriasis

Date TBD Date TBD

SEC 8-K verified 3mo ago

Countdown card →

ARQT

Arcutis Biotherapeutics, Inc.

AdCom AI-extracted

ZORYVE

atopic dermatitis

Date TBD Date TBD

SEC 8-K verified 3mo ago

Countdown card →

ARQT

Arcutis Biotherapeutics, Inc.

Phase 1 AI-extracted

ARQ-234

atopic dermatitis

Date TBD Date TBD

SEC 8-K verified 3mo ago

Countdown card →